EUVIMEDEUVIMED entdecken
Crossref

Berberine reshapes gut microbiota and attenuates bone loss in estrogen-deficient osteoporosis via the gut-bone axis

Leilei Huang, Xinxin Liu, Furong Huang, Lei Chen, Juanqing Yue

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-026-05326-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Leilei Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Wenzhou Integrated Traditional Chinese and Western Medicine Hospital, Wenzhou, 325000, Zhejiang, China. Hauptthemen laut MEDLINE: Berberine, Gastrointestinal Microbiome, Osteoporosis, Postmenopausal, Estrogens. Die Arbeit nennt 28 Literaturangaben. Gefördert von: the Basic Public Welfare Research Project of Zhejiang Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Postmenopausal osteoporosis (PMO) is a metabolic bone disorder characterized by estrogen deficiency-induced bone loss, deterioration of bone microstructure, and increased fracture risk. Current therapeutic agents are limited in efficacy and may have adverse effects. Berberine, a traditional Chinese medicinal compound, exhibits multitarget regulatory potential. However, its mechanism of action in alleviating PMO through modulation of the gut microbiota remains unclear. The objectives of this study are to assess the potential of berberine in mitigating estrogen deficiency-induced osteoporosis through modulation of the gut microbiota and to elucidate its underlying mechanisms. An ovariectomy (OVX)-induced PMO mouse model was established and divided into control, model, and berberine-treated (100 mg/kg/day) groups. Bone microstructure was examined using micro-CT, gut microbiota composition was analyzed through 16S rRNA sequencing; inflammatory factors and bone metabolism markers were evaluated using immunofluorescence; western blotting, qRT-PCR, and serum cytokine levels were quantified using ELISA. Berberine effectively reversed the OVX-induced gut dysbiosis by restoring the diminished levels of norank_f_Muribaculaceae and mitigating the elevated abundance of Lachnospiraceae_NK4A136_group, norank_f_Lachnospiraceae, and Roseburia. This modulation led to the suppression of intestinal inflammation, evidenced by decreased expression of IL-1β, IL-6, IL-8, and TNF-α, and an enhancement in gut barrier integrity, as indicated by increased levels of occludin and ZO-1. These changes collectively reduced the translocation of LPS into circulation. Consequently, berberine attenuated systemic and local release of pro-inflammatory cytokines and the activation of osteoclasts, resulting in the amelioration of PMO. Berberine mitigates PMO by reshaping the gut microbiota, improving intestinal barrier function, and suppressing systemic inflammation, thereby inhibiting bone resorption and restoring bone metabolic balance. This study offers a novel microbiome-targeted therapeutic approach for PMO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineGastrointestinal MicrobiomeOsteoporosis, PostmenopausalEstrogensAnimalsFemaleOvariectomyMiceCytokinesMice, Inbred C57BLDisease Models, AnimalBone and BonesDysbiosis

Stichwörter der Autor:innen

BerberineGut microbiotaGut-bone axisInflammationPostmenopausal osteoporosis

Substanzen

BerberineEstrogensCytokines

Autor:innen und Institutionen

  • Department of Orthopedics, Wenzhou Integrated Traditional Chinese and Western Medicine Hospital, Wenzhou, 325000, Zhejiang, China.
  • Department of Orthopedics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
  • Department of Orthopedics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China. chenlei689595@126.com.
  • Department of Pathology, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, 310000, Zhejiang, China. lolayue@foxmail.com.

Förderung

  • the Basic Public Welfare Research Project of Zhejiang Natural Science Foundation of China

Zitieren

APA

Huang, L., Liu, X., Huang, F., Chen, L., & Yue, J. (2026). Berberine reshapes gut microbiota and attenuates bone loss in estrogen-deficient osteoporosis via the gut-bone axis. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05326-5

Vancouver

Huang L, Liu X, Huang F, Chen L, Yue J. Berberine reshapes gut microbiota and attenuates bone loss in estrogen-deficient osteoporosis via the gut-bone axis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05326-5

BibTeX
@article{Huang2026,
  author = {Huang, Leilei and Liu, Xinxin and Huang, Furong and Chen, Lei and Yue, Juanqing},
  title = {Berberine reshapes gut microbiota and attenuates bone loss in estrogen-deficient osteoporosis via the gut-bone axis},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-05326-5}
}
Kostenlos starten →